Analyst Ims Investment Management Services Ltd. Biogen Inc. Transaction History
Analyst Ims Investment Management Services Ltd.
- $3.43 Billion
- Q4 2025
A detailed history of Analyst Ims Investment Management Services Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Analyst Ims Investment Management Services Ltd. holds 1,208 shares of BIIB stock, worth $202,400. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,208Holding current value
$202,400% of portfolio
0.01%Shares
15 transactions
Others Institutions Holding BIIB
# of Institutions
1,078Shares Held
131MCall Options Held
3.77MPut Options Held
2.31M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.9 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15MShares$2.51 Billion1.66% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.44 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.32MShares$1.23 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.25MShares$712 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $24.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...